Answers are grounded in this paper and cite their sources.
Commentary highlights a method generating organoids from adipose tissue, indicating a new approach to regenerative therapies.
Organoid technologies have emerged as powerful tools in regenerative medicine; however, current organoid technologies are predominantly based on pluripotent stem cell–derived systems, which poses challenges related to complexity, maturation, and clinical translation. In this commentary, we highlight a recent study by Huang et al. describing a tissue-level strategy for direct generation of functional multilineage organoids from human adult adipose tissue using reaggregated micro-fat (RMF). By preserving native tissue architecture and cellular heterogeneity, this approach enables the formation of mesoderm-, endoderm-, and ectoderm-derived organoids without genetic reprogramming or prolonged expansion culture. RMF-derived organoids demonstrate functional properties in vivo, including support of hematopoiesis and restoration of glycemic control in disease models. While further optimization and standardization will be required for clinical translation, this work provides a compelling alternative to conventional pluripotent stem cell–based paradigms and underscores the importance of tissue context in regenerative strategies. The study reframes adipose tissue as an integrated regenerative substrate and broadens the conceptual landscape of organoid generation toward more clinically accessible approaches.
No takes yet. Share an insight, caveat, or question.
Lum et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: